Ultralife Corporation
ULBI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $113,526 | $149,382 | $89,486 | $123,886 |
| - Cash | $9,260 | $10,941 | $8,719 | $6,854 |
| + Debt | $3,781 | $54,692 | $53,604 | $54,252 |
| Enterprise Value | $108,047 | $193,133 | $134,371 | $171,284 |
| Revenue | $43,371 | $48,561 | $50,746 | $43,852 |
| % Growth | -10.7% | -4.3% | 15.7% | – |
| Gross Profit | $9,619 | $11,601 | $12,745 | $10,599 |
| % Margin | 22.2% | 23.9% | 25.1% | 24.2% |
| EBITDA | $660 | $3,523 | $4,833 | $2,503 |
| % Margin | 1.5% | 7.3% | 9.5% | 5.7% |
| Net Income | -$1,220 | $879 | $1,865 | $194 |
| % Margin | -2.8% | 1.8% | 3.7% | 0.4% |
| EPS Diluted | -0.073 | 0.053 | 0.11 | 0.012 |
| % Growth | -238.8% | -52% | 848.3% | – |
| Operating Cash Flow | $174 | $5,935 | $3,368 | $3,046 |
| Capital Expenditures | -$995 | -$1,100 | -$895 | -$606 |
| Free Cash Flow | -$821 | $4,835 | $2,473 | $2,440 |